News – Page 384 – Endpoints News

Trodelvy notches a win in most common form of breast cancer

3 years ago

Neurodegenerative biotech Vyant warns of potential wind-down

3 years ago

Eisai cutting 91 jobs after out-license deal; Merck touts first-line Keytruda results in endometrial cancer

3 years ago

Sanofi scraps PhIII trial for Principia drug after reviewing competition

3 years ago

Behind Friday's $161M IPO: A star scientist, GPCR drug discovery and a plan to challenge pharma in diabetes

3 years ago

Canadian plant-based vaccine developer Medicago shutters months after layoffs

3 years ago

After 13 years, Ramy Mahmoud steps into CEO seat at Optinose; Rupert Vessey set to exit Bristol Myers in July

3 years ago

Gilead boasts its best growth since 2015 despite plunging sales of Covid treatment

3 years ago

Magenta halts stem cell work and may sell itself following patient death, clinical hold

3 years ago

Eli Lilly touts skyrocketing Mounjaro prescriptions even as it reports an overall slump in 2022 revenue

3 years ago

Bristol Myers turns attention to new products in wake of Revlimid patent loss

3 years ago

FTC makes an example of GoodRx, bans discounter from sharing private health data with advertisers

3 years ago

Roche writes off $3B+ in pipeline assets, $750M for Spark-acquired gene therapies

3 years ago

Merck’s Keytruda nears $21B in sales, doubles down on combo trials

3 years ago

J&J’s Janssen lays off employees at Pennsylvania, New Jersey sites

3 years ago

J&J’s Janssen ‘Blue Jacket’ fashion show returns to runway for prostate cancer awareness

3 years ago

How to use external controls: FDA spells out thinking in new draft guidance

3 years ago

BioNTech opens new plasmid DNA manufacturing facility in Germany

3 years ago

Manufacturing roundup: Catalent caps off manufacturing site in Belgium; EuroAPI restarts production in Hungary

3 years ago

The Big Pharma axe: Merck cuts chikungunya vax, Bristol Myers drops CytomX-partnered program, and more

3 years ago

Karuna licenses Goldfinch assets to compete with Boehringer Ingelheim in neuroscience

3 years ago

Roivant, Vera seek $100M+ raises as they look to fund drug hopefuls

3 years ago

Parthenon Therapeutics CEO exits weeks after co-founder leaves

3 years ago

Tonix snaps up assets from Healion Bio; Mesoblast gives its BLA another shot

3 years ago

First page Previous page 381 382 383384385 386 387 Next page Last page